CIK 0001659617
- Non-accelerated filer
- Smaller reporting company
Moleculin Biotech, Inc.
Sign in to watch- Ticker
- MBRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474671997
- Phone
- +1 713-300-5160
- Business address
- 5300 MEMORIAL DRIVE, SUITE 950, HOUSTON, TX, 77007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-17 | Cermak Elizabeth Director | Grant or award · Stock Options (right to buy) | +4,000 | 4,331 | ||
| 2026-11-17 | Climaco John M Director | Grant or award · Stock Options (right to buy) | +4,000 | 4,334 | ||
| 2026-11-17 | CANNON MICHAEL D Director | Grant or award · Stock Options (right to buy) | +4,000 | 4,334 | ||
| 2026-11-17 | George Robert E. Director | Grant or award · Stock Options (right to buy) | +4,000 | 4,334 | ||
| 2026-11-16 | Foster Jonathan P. Chief Financial Officer | Exercise or conversion | +362 | 20,595 | ||
| 2026-11-16 | Foster Jonathan P. Chief Financial Officer | Shares withheld for taxes | −89 | $7.14 | $635 | 20,506 |
| 2026-11-16 | Foster Jonathan P. Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −362 | 70,492 | ||
| 2026-11-16 | KLEMP WALTER V CEO and President | Exercise or conversion | +577 | 36,686 | ||
| 2026-11-16 | KLEMP WALTER V CEO and President | Shares withheld for taxes | −141 | $7.41 | $1K | 36,545 |
| 2026-11-16 | KLEMP WALTER V CEO and President | Exercise or conversion · Restricted Stock Units | −577 | 126,838 | ||
| 2026-11-04 | PICKER DONALD H Chief Science Officer | Exercise or conversion | +17 | 8,722 | ||
| 2026-11-04 | PICKER DONALD H Chief Science Officer | Shares withheld for taxes | −4 | $8.46 | $34 | 8,718 |
| 2026-11-04 | PICKER DONALD H Chief Science Officer | Exercise or conversion · Restricted Stock Units | −18 | 39,474 | ||
| 2026-11-04 | Foster Jonathan P. Chief Financial Officer | Exercise or conversion | +41 | 20,301 | ||
| 2026-11-04 | Foster Jonathan P. Chief Financial Officer | Shares withheld for taxes | −10 | $8.46 | $85 | 20,291 |
| 2026-11-04 | Foster Jonathan P. Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −41 | 70,854 | ||
| 2026-11-04 | KLEMP WALTER V CEO and President | Exercise or conversion | +57 | 36,217 | ||
| 2026-11-04 | KLEMP WALTER V CEO and President | Shares withheld for taxes | −14 | $8.46 | $118 | 36,203 |
| 2026-11-04 | KLEMP WALTER V CEO and President | Exercise or conversion · Restricted Stock Units | −57 | 127,415 | ||
| 2026-10-15 | PICKER DONALD H Chief Science Officer | Grant or award · Stock Options (right to buy) | +250,000 | 789,595 |
Page 1 of 14 · 279 trades